Perspectives in Medicinal Chemistry: Metalloprotein Inhibitors: What Have We Made and What is the Next Step?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|5|467-469

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.5, 2016-02, pp. : 467-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing a vaccine against congenital CMV infection: what have we learned from animal models? Where should we go next?

By Schleiss Mark R  

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1161-1182

Future Medicine

Access to resources Recommend Favorite

Myc - What We have Learned from Flies

By  

Current Drug Targets, Vol. 10, Iss. 7, 2009-07 ,pp. : 590-601

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 3, 2010-02 ,pp. : 232-256

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Sirtuin Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 13, 2011-05 ,pp. : 1936-1946

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives in Medicinal Chemistry:

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-02 ,pp. : 381-2

Bentham Science Publishers

Access to resources Recommend Favorite